{{Rsnum
|rsid=315951
|Gene=IL1RN
|Chromosome=2
|position=113133009
|Orientation=minus
|GMAF=0.3994
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=IL1RN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 3.1 | 45.3 | 51.6
| HCB | 22.7 | 54.5 | 22.7
| JPT | 42.2 | 46.7 | 11.1
| YRI | 22.2 | 63.5 | 14.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 22.7 | 54.5 | 22.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19280228
|Title=Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy
}}

{{PMID Auto
|PMID=20709104
|Title=Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans
}}

{{PMID Auto
|PMID=16106254
|Title=Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=17176440
|Title=The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus.
}}

{{PMID Auto
|PMID=18063673
|Title=Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis.
}}

{{PMID Auto
|PMID=19230157
|Title=Immunogenetics of seasonal influenza vaccine response.
|OA=1
}}

{{PMID Auto
|PMID=19505919
|Title=Toll-like receptor signaling pathway variants and prostate cancer mortality.
|OA=1
}}

{{PMID Auto
|PMID=20975573
|Title=Interleukin 1 beta (IL-1B) and IL-1 antagonist receptor (IL-1RN) gene polymorphisms are associated with the genetic susceptibility and steroid dependence in patients with ulcerative colitis.
}}

{{PMID Auto
|PMID=23765978
|Title=Association between IL-1RN gene polymorphisms and susceptibility to ankylosing spondylitis: a large Human Genome Epidemiology review and meta-analysis
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}